Thyrotoxicosis with diffuse goitre

E4_THYTOXGOITDIF

Graves disease: Graves' disease is an autoimmune disorder that leads to overactivity of the thyroid gland ( hyperthyroidism ).It is caused by an abnormal immune system response that causes the thyroid gland to produce too much thyroid hormones. Graves disease is the most common cause of hyperthyroidism andoccurs mostoften in women over age 20. However, the disorder may occur at any age and may affect males as well.Treatmentmayinclude radioiodine therapy , antithyroid drugs, and/or thyroid surgery.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E05.0 Hospital discharge: ICD-9 — 2420 Hospital discharge: ICD-8 — 2420 Cause of death: ICD-10 — E05.0 Cause of death: ICD-9 — 2420 Cause of death: ICD-8 — 2420 2 out of 7 registries used, show all original rules.	6220
4. Check minimum number of events None	6220
5. Include endpoints None	6220
6. Filter based on genotype QC (FinnGen only)	6220

Control definitions (FinnGen only)

Control exclude: E4_THYROID

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E05
Name in latin: Thyreotoxicosis cum struma diffusa

NAME	E4_THYTOXGOITDIF
CONTROL_EXCLUDE	E4_THYROID
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E050
HD_ICD_9	2420
HD_ICD_8	2420
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E050
COD_ICD_9	2420
COD_ICD_8	2420
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Thyrotoxicosis with diffuse goitre based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Autoimmune hyperthyroidism

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	38371	31186	6900
Only index persons	35764	29429	6335
Unadjusted period prevalence (%)
Whole population	0.76	0.89	0.19
Only index persons	0.93	1.08	0.24
Median age at first event (years)
Whole population	49.44	49.13	51.36
Only index persons	48.69	48.33	50.36

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6220	5214	1006
Unadjusted period prevalence (%)	1.56	1.78	0.44
Median age at first event (years)	49.24	48.24	54.37

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5573: Matched controls
55738

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E03.89

ICD-10 Finland

Other specified hypothyroidism

237.3

323.0

397

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

2364.7

323.0

764

BAA60

NOMESCO Finland

Total thyroidectomy

1113.0

323.0

1080

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

4035.9

323.0

387

H03AA01

ATC

levothyroxine sodium; systemic

178.1

323.0

3871

700

T86

ICPC

Hypothyroidism/myxoedema

83.7

323.0

446

104

Kela drug reimbursment

Thyroid insufficiency

2104.3

323.0

1524

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

4503599627370496.0

323.0

5146

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

8534.3

323.0

752

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

827.5

323.0

457

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

2418.0

323.0

2288

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

444.6

323.0

740

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

+∞

323.0

592

E03

ICD-10 Finland

Other hypothyroidism

74.9

323.0

499

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

100.3

323.0

1081

133

C07AA05

ATC

propranolol; systemic

5.0

323.0

2279

6805

H03BB01

ATC

carbimazole; oral

5082.5

323.0

4396

T85

ICPC

Hyperthyroidism/thyrotoxicosis

182.1

265.9

277

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

31.9

265.2

356

119

H06.2

ICD-10 Finland

Dysthyroid exophthalmos

+∞

239.3

228

C07AB07

ATC

bisoprolol; oral

2.6

234.6

2699

14873

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

29.6

223.8

306

109

H062, E050

ICD-10 Finland

+∞

204.4

195

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

+∞

194.9

186

EP1AE

NOMESCO Finland

Neck ultrasound examination

6.0

189.0

557

1005

24209

ICD-8 Finland

Thyrotoxicosis with or without goitre, Cum struma diffuse NUD

+∞

184.4

176

E05.80

ICD-10 Finland

Subacute thyrotoxicosis

143.5

182.6

194

2420A

ICD-9 Finland

Thyrotoxicosis with or without goitre, Toxic diffuse goitre

+∞

168.6

161

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

34.5

166.6

219

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

81.1

166.5

188

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.1

146.6

2553

15925

24200

ICD-8 Finland

Thyrotoxicosis with or without goitre, Cum struma diffusa et exophthalmo. Morbus Basedowi

+∞

145.4

139

E05.89

ICD-10 Finland

Other thyrotoxicosis

+∞

138.1

132

E05.1

ICD-10 Finland

Thyrotoxicosis with toxic single thyroid nodule

+∞

126.5

121

H03BA02

ATC

propylthiouracil; oral

+∞

118.1

113

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

117.6

1975

11810

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

37.2

107.2

138

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

+∞

97.1

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

244.1

93.9

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

14.7

93.3

160

112

E06.3

ICD-10 Finland

Autoimmune thyroiditis

64.9

87.9

102

2505

FHL

Bilateral resection (also used if total removal has been performed on the other side)

105.1

85.1

H05.2

ICD-10 Finland

Exophthalmic conditions

47.9

81.1

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

15.6

79.8

133

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

66.0

78.7

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

4.4

74.3

287

684

E05.5

ICD-10 Finland

Thyroid crisis or storm

+∞

72.0

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

110.1

70.0

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

+∞

62.6

H02AB06

ATC

prednisolone; systemic

1.6

59.4

2426

18099

E89.0

ICD-10 Finland

Postprocedural hypothyroidism

+∞

57.4

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

16.3

57.0

E06.1

ICD-10 Finland

Subacute thyroiditis

+∞

56.3

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

11.5

55.3

105

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

6.7

54.0

142

217

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

38.2

53.5

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

21.4

50.0

BAA25

NOMESCO Finland

Bilateral partial excision of thyroid gland

+∞

49.0

E06.2

ICD-10 Finland

Chronic thyroiditis with transient thyrotoxicosis

+∞

49.0

CA1AD

NOMESCO Finland

Orbita CT

30.3

47.1

H53.2

ICD-10 Finland

Diplopia

3.8

45.7

200

535

CAC30

NOMESCO Finland

Decompression of orbit to sinuses

451.3

45.3

A11CC03

ATC

alfacalcidol; systemic

5.1

45.3

148

297

E05.4

ICD-10 Finland

Thyrotoxicosis factitia

+∞

44.8

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

44.6

577

2956

H50.2

ICD-10 Finland

Vertical strabismus

9.4

43.4

C07AB02

ATC

metoprolol; systemic

1.8

42.7

893

5431

106

Kela drug reimbursment

Hypoparathyroidism

43.7

42.2

E06.9

ICD-10 Finland

Thyroiditis, unspecified

46.7

41.9

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

41.3

811

4827

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

37.5

1294

9001

ZXA10

NOMESCO Finland

Bilateral

1.7

35.5

902

5780

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.8

35.1

230

830

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.8

34.6

719

4339

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.9

34.5

510

2738

BAA50

NOMESCO Finland

Lobectomy and resection of contralateral lobe of thyroid gland

+∞

34.4

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

32.9

1776

13562

CAC44

NOMESCO Finland

Combined decompression of orbit

+∞

32.3

24199

ICD-8 Finland

Non-toxic nodular goitre, Unspecified

+∞

32.3

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

30.3

1837

14283

E83.51

ICD-10 Finland

Hypocalcemia

10.3

30.3

24220

ICD-8 Finland

Thyrotoxicosis with or without goitre, Thyrotoxicosis without mention of goitre

+∞

30.2

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.3

29.8

157

490

XCK00

NOMESCO Finland

Perimetry

2.1

29.0

330

1591

24210

ICD-8 Finland

Thyrotoxicosis with or without goitre, Toxic nodular goitre

28.0

28.8

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.5

27.8

235

983

H04AA01

ATC

glucagon; nasal, parenteral

3.4

27.6

136

404

TFP20

NOMESCO Finland

Cardiodefibrillation

2.3

27.1

257

1141

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

26.9

925

6361

T89

ICPC

Diabetes insulin dependent

2.7

26.2

188

717

A11CC02

ATC

dihydrotachysterol; oral

36.9

26.1

R00.2

ICD-10 Finland

Palpitations

1.9

25.8

381

2042

H50.6

ICD-10 Finland

Mechanical strabismus

73.0

25.8

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

25.7

1057

7558

CBK00

NOMESCO Finland

Myotomy or resection of tarsal muscle or levator muscle of eyelid for correction of retraction

135.6

25.6

H02AB07

ATC

prednisone; oral

1.6

24.9

677

4386

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

24.5

1944

15695

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.6

24.1

177

687

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.7

23.6

162

604

H02AB09

ATC

hydrocortisone; systemic

3.4

23.4

115

342

E05.3

ICD-10 Finland

Thyrotoxicosis from ectopic thyroid tissue

+∞

22.9

XCD10

NOMESCO Finland

Electrophysiological examination of eye

3.0

22.7

132

443

CAC20

NOMESCO Finland

Lateral decompression of orbit

120.5

22.6

C07AA07

ATC

sotalol; systemic

2.8

22.4

146

529

H50.8

ICD-10 Finland

Other specified strabismus

21.4

22.1

C01BD01

ATC

amiodarone; systemic

3.3

22.0

111

337

A02BC02

ATC

pantoprazole; systemic

1.3

21.7

3149

27675

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.1

21.2

117

380

K90.0

ICD-10 Finland

Coeliac disease

2.5

21.1

165

664

CEC00

NOMESCO Finland

Recession of extraocular muscle

8.7

21.0

C03CA01

ATC

furosemide; systemic

1.5

21.0

944

6843

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.0

20.9

291

1523

ZX120

NOMESCO Finland

Intravenous

1.7

20.9

424

2524

A10AA02

ATC

2.6

20.6

151

585

N02BE01

ATC

paracetamol; systemic, rectal

1.4

20.6

4466

41502

A10AA01

ATC

2.7

19.8

134

495

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

19.3

1217

9378

A10AE04

ATC

insulin glargine; parenteral

1.8

19.3

336

1909

R94.6

ICD-10 Finland

Abnormal results of thyroid function studies

8.7

18.8

R53

ICD-10 Finland

Malaise and fatigue

1.4

18.7

890

6510

E07.9

ICD-10 Finland

Disorder of thyroid, unspecified

23.7

18.6

A10AE05

ATC

insulin detemir; parenteral

2.1

18.6

215

1045

K29.4

ICD-10 Finland

Chronic atrophic gastritis

3.6

18.5

236

207

Kela drug reimbursment

Chronic arrhythmias

1.7

18.4

439

2739

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

18.3

776

5544

H3600, E103

ICD-10 Finland

4.3

18.3

160

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

18.2

1820

15041

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

17.7

R06.0

ICD-10 Finland

Dyspnoea

1.4

17.5

1009

7637

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

17.2

381

2328

H02.5

ICD-10 Finland

Other disorders affecting eyelid function

12.6

17.1

CA1BD

NOMESCO Finland

Extensive orbita CT

31.5

17.0

B01AA03

ATC

warfarin; systemic

1.5

16.9

602

4146

K04

ICPC

Palpitations/awareness of heart

1.9

16.8

242

1287

E06.0

ICD-10 Finland

Acute thyroiditis

63.5

16.7

E89.9

ICD-10 Finland

Postprocedural endocrine and metabolic disorder, unspecified

+∞

16.7

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.1

16.6

297

WX110

NOMESCO Finland

Local anesthesy

1.3

16.4

3484

31590

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.8

16.1

104

377

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.8

16.1

284

1620

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

24.5

16.0

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

15.8

507

3407

CA1BM

NOMESCO Finland

Eye and orbita MRI examination with 3 Tesla magnet

60.2

15.7

E06.4

ICD-10 Finland

Drug-induced thyroiditis

+∞

15.6

M14.5*E03.9

ICD-10 Finland

Arthropathy in hypothyroidism (E00-E03+)

+∞

15.6

H50.0

ICD-10 Finland

Convergent concomitant strabismus

5.3

15.5

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

15.5

642

4561

Z3231

NOMESCO Finland

Registered nurse

1.3

15.4

1178

9314

B03BA03

ATC

hydroxocobalamin; parenteral

2.0

15.4

200

1022

107

Kela drug reimbursment

Pernicious anaemia

3.1

14.9

264

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

56.8

14.8

2AB04

NOMESCO Finland

8.2

14.7

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

14.6

916

7010

G73.0*E05.9

ICD-10 Finland

Myasthenic syndromes in thyrotoxicosis [hyperthyroidism]

+∞

14.6

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

14.5

594

4205

E20.8

ICD-10 Finland

Other hypoparathyroidism

150.4

14.5

WF099

NOMESCO Finland

Other radiotherapy

5.5

14.4

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

7.3

14.4

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

14.2

1352

11017

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

14.2

410

2690

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

14.1

1046

8225

A04

ICPC

Weakness/tiredness general

1.5

13.9

534

3732

SPAT1097

SPAT

Recording of ECG

1.5

13.8

558

3943

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

5.0

13.8

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

11.4

13.8

K80

ICPC

Cardiac arrhythmia NOS

1.7

13.7

300

1830

C01AA05

ATC

digoxin; systemic

1.9

13.6

211

1154

E50.0

ICD-10 Finland

Vitamin A deficiency with conjunctival xerosis

75.3

13.6

6481B

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Thyroid dysfunction[HYPOTHYREOSIS IN GRAVIDITATE]

140.3

13.4

ZXE00

NOMESCO Finland

One hour or less

1.3

13.4

1880

16066

J01DB01

ATC

cefalexin; oral

1.3

13.3

4157

38896

SPAT1263

SPAT

Sampling

1.3

13.3

1973

16968

SPAT1262

SPAT

Handing over of treatment supplies

1.4

13.3

648

4745

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

13.2

2706

24126

CEW99

NOMESCO Finland

Other operation on extraocular muscle

13.8

13.2

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

13.1

327

2064

J01AA02

ATC

doxycycline; systemic

1.3

13.1

3941

36666

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

12.7

345

2223

N05CF01

ATC

zopiclone; oral

1.3

12.7

1348

11116

H3601, E103

ICD-10 Finland

4.3

12.7

108

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

12.7

738

5572

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

12.7

280

1710

24400

ICD-8 Finland

Myxoedema, (hypothyreosis) post therapiam

+∞

12.5

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

2.6

12.4

334

A10AE06

ATC

insulin degludec; parenteral

2.3

12.4

115

511

R03AC02

ATC

salbutamol; inhalant

1.2

12.4

2553

22715

WX402

NOMESCO Finland

General anaesthesia

1.4

12.3

738

5594

CEC90

NOMESCO Finland

Total transposition of extraocular muscle or muscles

37.6

12.2

E07.89

ICD-10 Finland

Other specified disorders of thyroid

37.6

12.2

A02BC01

ATC

omeprazole; systemic

1.3

12.1

1153

9363

N05BA04

ATC

oxazepam; oral

1.3

12.0

1097

8858

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.9

12.0

124

R01AD08

ATC

fluticasone; nasal

1.3

11.9

1349

11199

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

11.7

352

2329

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

11.7

1668

14234

A02BC05

ATC

esomeprazole; systemic

1.2

11.7

1819

15672

BAA20

NOMESCO Finland

Unilateral partial excision of thyroid gland

65.1

11.6

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.6

11.5

305

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

4.7

11.5

M14.5*E05.9

ICD-10 Finland

Arthropathy in thyrotoxicosis [hyperthyroidism]

+∞

11.5

E03.8

ICD-10 Finland

Other specified hypothyroidism

+∞

11.5

GB1AA

NOMESCO Finland

Tracheal X-ray examination

120.2

11.4

K02.1

ICD-10 Finland

Caries of dentine

1.2

11.4

2767

24952

SGA01

NOMESCO Finland

Tooth opening as first aid

1.3

11.1

718

5505

CEC60

NOMESCO Finland

Transposition of extraocular muscle with adjustable suture

12.7

11.1

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

7.1

11.0

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

3.0

11.0

199

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

10.9

207

1214

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.7

10.8

126

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

3.3

10.7

159

105

Kela drug reimbursment

Adrenal cortical hypofunction

10.0

10.5

R50.9

ICD-10 Finland

Fever, unspecified

1.4

10.5

522

3834

H03BB02

ATC

thiamazole; oral

110.2

10.4

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

2.6

10.2

278

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.2

10.1

160

N07BA03

ATC

varenicline; oral

1.7

10.1

223

1366

8341/3-C73.9

ICD-O-3

Papillary microcarcinoma of thyroid gland

40.1

10.0

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.7

9.8

219

1343

SPAT1301

SPAT

No procedures

1.2

9.8

1315

11098

E23.05

ICD-10 Finland

Lack of TSH

26.0

9.8

D51.0

ICD-10 Finland

Vitamin B12deficiency anaemia due to intrinsic factor deficiency

5.4

9.8

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

9.7

723

5663

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

9.6

2153

19149

CEC10

NOMESCO Finland

Recession and resection of extraocular muscle

3.8

9.6

104

2504

FHL

Unilateral resection or enucleation

9.1

9.5

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

9.5

426

3072

E05.81

ICD-10 Finland

Overproduction of thyroid-stimulating hormone

100.2

9.4

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

9.4

2314

20748

N05CF02

ATC

zolpidem; oral

1.3

9.4

789

6284

A29

ICPC

General symptom/complaint other

1.4

9.4

411

2948

2440A

ICD-9 Finland

Acquired hypothyroidism, Postsurgical hypothyroidism

+∞

9.4

8340/3-C73.9

ICD-O-3

Papillary carcinoma, follicular variant of thyroid gland

+∞

9.4

E05.8

ICD-10 Finland

Other thyrotoxicosis

+∞

9.4

24110

ICD-8 Finland

Non-toxic nodular goitre, Sporadic

+∞

9.4

B01AF02

ATC

apixaban; oral

1.5

9.4

273

1798

J01CA04

ATC

amoxicillin; systemic

1.2

9.3

4160

39401

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

9.3

3544

33055

J01FA10

ATC

azithromycin; systemic

1.2

9.2

2938

26946

C01BC04

ATC

flecainide; systemic

2.0

9.2

108

537

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

9.2

227

1434

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

9.2

1002

8252

B81

ICPC

Anaemia vit B12/folate deficiency

1.9

9.1

121

631

TFP34

NOMESCO Finland

Electrophysiological investigation

2.0

9.0

108

543

N02AX02

ATC

tramadol; systemic, rectal

1.2

9.0

1734

15178

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

9.0

501

3751

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

8.8

286

1930

XF404

NOMESCO Finland

Ambulatory ECG

1.5

8.8

316

2181

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

8.8

556

4249

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.7

8.8

180

1083

A60

ICPC

General and Unspecified, Result test/procedure

1.7

8.7

171

1014

R06AE07

ATC

cetirizine; oral

1.2

8.7

2143

19177

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.1

8.6

434

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

8.6

279

1885

E04.8

ICD-10 Finland

Other specified nontoxic goitre

16.3

8.5

L28

ICPC

Limited function/disability (L)

1.3

8.4

542

4150

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

5.1

8.4

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

8.4

993

8249

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

+∞

8.3

2506

FHL

Thyroidectomy

+∞

8.3

O992, E050

ICD-10 Finland

+∞

8.3

2441A

ICD-9 Finland

Acquired hypothyroidism, Other postablative hypothyroidism

+∞

8.3

E06.5

ICD-10 Finland

Other chronic thyroiditis

+∞

8.3

WX290

NOMESCO Finland

Other blockade of nerve

1.2

8.3

2107

18875

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.5

8.3

262

1758

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.4

8.3

409

3002

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

8.3

1801

15917

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

8.2

2079

18613

B01AB05

ATC

enoxaparin; parenteral

1.2

8.2

1234

10512

J01FA06

ATC

roxithromycin; oral

1.2

8.2

1860

16496

J01DA01

ATC

[U] cefalexin; systemic

1.2

8.1

3063

28361

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.7

8.1

155

916

R63.4

ICD-10 Finland

Abnormal weight loss

1.9

8.1

121

660

G47.3

ICD-10 Finland

Sleep apnoea

1.3

8.0

692

5529

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

8.0

1174

9978

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.9

8.0

117

636

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

8.0

937

7769

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.7

8.0

164

991

R11

ICD-10 Finland

Nausea and vomiting

1.4

7.9

308

2163

N06AX21

ATC

duloxetine; oral

1.4

7.9

447

3354

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.7

7.9

154

915

WZC30

NOMESCO Finland

Teaching

1.3

7.8

485

3693

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.1

7.8

397

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.6

7.8

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

7.8

687

5498

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

4.6

7.8

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

7.8

781

6359

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.2

7.7

1431

12439

CKC12

NOMESCO Finland

Photocoagulation of retina

1.7

7.7

144

842

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.7

7.7

187

4CJ01

NOMESCO Finland

45.0

7.7

TBA20

NOMESCO Finland

Aspiration cytology of thyroid gland

45.0

7.7

-60

ICPC

Result test/procedure

1.5

7.6

232

1548

R05

ICPC

Cough

1.2

7.6

955

7973

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

7.6

392

2897

O90.5

ICD-10 Finland

Postpartum thyroiditis

25.0

7.6

J01FA09

ATC

clarithromycin; systemic

1.2

7.5

1455

12702

R01AD09

ATC

mometasone; nasal

1.2

7.5

2173

19642

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

7.4

585

4614

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

7.4

1517

13301

BWD00

NOMESCO Finland

Reoperation for deep haemorrhage in endocrine surgery

80.2

7.4

Z50.5

ICD-10 Finland

Speech therapy

2.7

7.4

180

SPAT1283

SPAT

Restricted health certificate

1.2

7.4

848

7007

A09

ICPC

Sweating problem

2.6

7.4

187

T81

ICPC

Goitre

6.0

7.4

R49.08

ICD-10 Finland

Other specified dysphonia

2.0

7.3

466

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

3.1

7.3

125

3762A

ICD-9 Finland

Disorders of the orbit, Endocrine exophthalmos

+∞

7.3

E03.4

ICD-10 Finland

Atrophy of thyroid (acquired)

+∞

7.3

M03BX02

ATC

tizanidine; oral

1.2

7.3

3069

28555

M54.5

ICD-10 Finland

Low back pain

1.2

7.3

1474

12907

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.5

7.2

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.6

7.2

173

1088

C08CA01

ATC

amlodipine; oral

1.2

7.2

1190

10219

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

7.1

514

4004

A98

ICPC

Health maint/preventive medicine

1.4

7.1

5252

51428

M25.5

ICD-10 Finland

Pain in joint

1.2

7.1

1272

11009

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

7.1

2107

19054

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

7.1

615

4915

AR6

Catheter ablation of arrhythmia, target: atrial fibrillation

5.3

7.1

R60.0

ICD-10 Finland

Localized oedema

1.4

7.0

377

2807

D01

ICPC

Abdominal pain/cramps general

1.3

7.0

438

3341

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

3.2

7.0

107

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

7.0

240

1645

C01BD07

ATC

dronedarone; oral

3.8

6.9

H57.1

ICD-10 Finland

Ocular pain

1.7

6.9

128

753

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

6.9

605

4842

H02AB04

ATC

methylprednisolone; systemic

1.3

6.8

583

4646

F29

ICPC

Eye symptom/complaint other

1.4

6.8

318

2312

J02AC01

ATC

fluconazole; systemic

1.2

6.8

2179

19801

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

6.8

2371

21695

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

6.8

2766

25607

A12AA04

ATC

calcium carbonate; oral

2.5

6.7

198

C03DA01

ATC

spironolactone; oral

1.4

6.7

308

2232

H01.0

ICD-10 Finland

Blepharitis

1.5

6.6

214

1450

R03BB04

ATC

tiotropium bromide; inhalant

1.4

6.5

292

2111

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

6.5

1787

16033

-50

ICPC

Medication/prescr/renewal

1.6

6.5

144

889

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

6.5

268

1908

M01AH01

ATC

celecoxib; oral (coxibs)

1.2

6.5

723

5957

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

6.4

157

996

R21

ICPC

Throat symptom/complaint

1.2

6.4

908

7668

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

6.4

1135

9801

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

1.7

6.4

113

655

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.2

6.4

1118

9641

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

69.9

6.4

E89

ICD-10 Finland

Postprocedural endocrine and metabolic disorders, not elsewhere classified

69.9

6.4

342

Kela drug reimbursment

Dronedarone

3.3

6.4

N06AX11

ATC

mirtazapine; oral

1.2

6.4

1344

11789

P06

ICPC

Sleep disturbance

1.3

6.4

369

2781

XCH00

NOMESCO Finland

Eye pressure measurement

1.7

6.3

136

832

RP210

NOMESCO Finland

6.5

6.3

A99

ICPC

Disease/condition unspecnature/site

1.4

6.3

277

1992

C10AA03

ATC

pravastatin; oral

1.5

6.3

197

1322

-34

ICPC

Blood test

1.7

6.3

115

672

R01AD12

ATC

fluticasone furoate; nasal

1.2

6.3

1398

12317

T08

ICPC

Weight loss

2.3

6.3

225

CE2W4

NOMESCO Finland

Eye movement mapping

5.5

6.3

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

6.3

495

3908

K78

ICPC

Atrial fibrillation/flutter

1.5

6.3

189

1262

E50.9

ICD-10 Finland

Vitamin A deficiency, unspecified

18.0

6.3

E8901, E050

ICD-10 Finland

+∞

6.2

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

+∞

6.2

BA1AN

NOMESCO Finland

Thyroid gland isotope imaging

+∞

6.2

2410A

ICD-9 Finland

Non-toxic nodular goitre, Non-toxic uninodular goitre

+∞

6.2

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

6.2

757

6290

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

6.2

817

6850

N03AX12

ATC

gabapentin; oral

1.3

6.2

593

4795

L04

ICPC

Chest symptom/complaint

1.5

6.2

215

1477

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

2.4

6.2

189

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.2

6.2

748

6215

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

6.2

2490

22967

J01MA12

ATC

levofloxacin; systemic

1.3

6.2

633

5160

G44.2

ICD-10 Finland

Tension-type headache

1.3

6.2

575

4635

CS494

NOMESCO Finland

Other visual field testing

1.9

6.1

411

SPAT1312

SPAT

General health counselling

1.2

6.1

1379

12161

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

6.1

1575

14044

H50.52

ICD-10 Finland

Exophoria

2.4

6.1

196

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

6.1

1715

15404

AA1AD

NOMESCO Finland

CT of head and brain

1.2

6.0

788

6604

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1684

2986

7.36

307.65

1.4

1.1

iu/ml

229.7

89.9

24.72

930

1035

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

2963

608

92.17

307.65

3.3

1.2

iu/l

22.7

2.7

1.12

1960

126

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3323

1822

38.02

307.65

7.8

1.6

pmol/l

4.8

4.5

12.82

3124

1607

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5931

39955

11.46

307.65

14.4

2.6

pmol/l

15.6

14.3

286.01

5738

36532

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5985

47844

7.67

274.23

15.5

3.4

mu/l

1.7

2.0

3.24

5779

44231

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3606

22922

2.36

232.20

7.2

6.0

mmol/l

1.2

2.59

3037

19327

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

929

3155

3.29

214.04

3.1

3.5

ng/l

61.7

87.3

16.36

831

2727

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3255

20615

2.21

200.43

6.1

5.3

mmol/l

1.2

1.17

3004

18678

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

128

31.85

197.56

4.7

1.7

—

(3018418) pH of Serum or Plasma

2367

13649

2.19

179.13

4.8

3.7

7.4

0.43

449

2573

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

144

15.49

165.13

1.6

1.2

pmol/l

16.1

13.5

3.68

128

(3013650) Neutrophils [#/volume] in Blood by Automated count

4052

29228

2.11

163.39

9.5

8.9

e9/l

3.8

4.0

9.64

3590

25552

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

186

189

10.11

163.04

3.9

1.2

u/ml

152.3

139.3

0.05

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4816

38286

2.14

134.12

8.5

7.1

u/l

78.3

76.3

2.86

4601

36018

(3015377) Calcium [Moles/volume] in Serum or Plasma

2521

16232

1.93

129.91

3.1

3.3

mmol/l

2.3

2.4

18.81

2257

14255

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3058

21523

1.83

114.43

2.5

2.2

nmol/l

75.9

77.1

1.65

2790

19643

(3001019) Free T4 and TSH panel - Serum or Plasma

718

3000

2.58

109.07

2.3

1.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

4630

38091

1.84

92.51

4.3

3.9

mm/h

11.6

0.01

4354

35495

(40758558) Short blood count panel - Blood

1912

12696

1.73

79.24

7.5

6.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

5777

52320

2.47

74.86

15.9

13.2

mmol/l

139.7

0.33

5660

50972

(3023103) Potassium [Moles/volume] in Serum or Plasma

5788

52504

2.48

74.01

16.1

13.3

mmol/l

3.9

1.05

5661

51037

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1815

12127

1.70

72.19

1.4

1.3

u/ml

1.7

1.5

0.34

487

3316

(3036481) Cortisol [Moles/volume] in Serum or Plasma

810

4297

2.02

67.61

2.1

2.0

nmol/l

373.7

377.3

0.20

743

3955

(3013115) Eosinophils [#/volume] in Blood

3301

26099

1.56

63.09

5.7

6.0

e9/l

0.2

0.57

2957

23027

(3022096) Basophils/100 leukocytes in Blood

2953

22786

1.56

62.74

5.8

6.0

0.7

0.72

2746

21247

(3002030) Lymphocytes/100 leukocytes in Blood

3120

24410

1.56

62.08

5.8

5.9

28.9

28.7

0.28

2905

22794

(3018010) Neutrophils/100 leukocytes in Blood

3076

24091

1.55

60.19

5.6

5.7

56.4

56.9

1.85

2872

22568

(3006504) Eosinophils/100 leukocytes in Blood

3020

23562

1.55

60.09

5.7

5.9

2.8

0.31

2813

21960

(3019069) Monocytes/100 leukocytes in Blood

3028

23677

1.54

59.37

6.0

6.2

8.5

8.3

3.72

2826

22213

(3044889) 12 lead EKG panel

4108

34400

1.57

58.78

3.8

3.3

—

(3019198) Lymphocytes [#/volume] in Blood

3255

25900

1.54

58.62

5.5

5.8

e9/l

1.9

2.41

2929

22919

(3006315) Basophils [#/volume] in Blood

3176

25201

1.53

57.47

5.5

5.8

e9/l

0.0

2.99

2792

21837

(3001604) Monocytes [#/volume] in Blood

3157

25110

1.52

55.84

5.5

5.7

e9/l

0.6

0.04

2783

21770

(42870588) Differential panel, method unspecified - Blood

2235

16566

1.55

54.48

5.5

5.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5931

55363

2.54

54.21

12.8

9.5

u/l

24.5

24.9

0.97

5807

53551

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

244

849

2.95

52.04

2.1

2.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5353

48430

1.76

50.29

13.4

11.0

ml/min/173m2

85.1

84.6

1.00

4580

39634

(3013826) Glucose [Moles/volume] in Serum or Plasma

3395

27761

1.49

50.21

4.6

4.2

mmol/l

6.6

6.5

1.91

3164

25661

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2959

23633

1.48

48.59

3.2

2.8

ug/l

98.0

100.5

0.27

2775

22167

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5106

45812

1.64

47.10

5.8

4.9

mmol/mol

39.5

38.6

8.03

4755

42704

(3007164) IgA [Mass/volume] in Serum or Plasma

1489

10376

1.57

46.27

1.5

1.4

g/l

2.2

2.3

2.49

881

6389

(3021589) Normoblasts [#/volume] in Blood

2789

22249

1.46

44.70

10.9

8.7

e9/l

0.0

1.19

2337

18060

(3003458) Phosphate [Moles/volume] in Serum or Plasma

874

5380

1.73

44.25

4.7

5.4

mmol/l

1.1

1.0

3.00

812

5015

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5635

52177

1.85

43.36

14.2

12.2

mg/l

19.5

21.8

6.22

4515

40464

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

270

1100

2.52

42.36

1.3

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5392

49568

1.66

39.19

4.5

4.0

mmol/l

5.8

4.47

4985

45717

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2378

18806

1.43

37.87

2.0

1.9

pmol/l

97.5

98.0

0.18

1225

9473

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

618

3726

1.73

33.19

3.8

3.4

mmol/l

1.2

2.94

544

3267

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3021

25262

1.38

33.16

5.7

5.9

umol/l

10.6

10.5

0.05

2858

23884

(40761511) CBC panel - Blood by Automated count

5804

54859

1.87

33.06

15.8

11.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2508

20397

1.38

32.36

4.3

4.5

g/l

35.9

36.0

0.41

2315

18948

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1552

11618

1.45

32.18

2.3

2.2

mg/l

2.8

2.9

0.33

1348

9981

(3019225) pH of Specimen

706

4465

1.66

31.64

4.6

3.8

—

(3002385) Erythrocyte distribution width [Ratio]

4852

44108

1.46

31.46

20.1

14.7

13.6

0.74

4771

43196

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1030

7137

1.53

31.27

3.1

3.3

mmol/l

0.8

1.75

963

6684

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1490

11266

1.42

28.70

3.3

2.8

ng/l

1209.6

1125.4

0.36

1269

9579

(3044640) Blood type and Crossmatch panel - Blood

2000

15941

1.38

28.11

2.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2090

16901

1.36

26.38

3.6

3.1

ng/l

73.5

71.5

0.01

1243

10008

(3007461) Platelets [#/volume] in Blood

6054

58558

2.28

24.77

25.1

17.9

e9/l

261.8

261.4

0.22

5967

57171

(3035941) MCH [Entitic mass]

6056

58590

2.28

24.69

25.0

17.8

30.0

30.2

7.32

6013

57864

(3024731) MCV [Entitic volume]

6056

58596

2.28

24.58

25.0

17.8

90.5

90.8

6.19

6013

57872

(3026361) Erythrocytes [#/volume] in Blood

6056

58603

2.27

24.45

25.1

17.8

e12/l

4.5

20.76

5945

57086

(3000963) Hemoglobin [Mass/volume] in Blood

6057

58621

2.28

24.37

25.2

17.9

g/l

134.9

133.8

10.97

6012

57889

(3022948) Iron [Moles/volume] in Serum or Plasma

970

6956

1.47

24.36

2.5

2.3

umol/l

13.5

13.4

0.05

882

6456

(3013512) EKG study

1647

12959

1.37

24.35

3.8

3.4

—

(3010813) Leukocytes [#/volume] in Blood

6056

58613

2.27

24.27

25.2

17.9

e9/l

6.5

6.6

3.27

5948

57073

(3004789) Transferrin [Mass/volume] in Serum or Plasma

898

6363

1.48

23.93

2.4

2.3

g/l

2.4

1.59

819

5910

(40760892) CBC W Ordered Manual Differential panel - Blood

1481

11539

1.37

23.07

3.9

4.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1866

15129

1.33

22.23

2.4

u/l

54.7

57.4

2.54

1712

13952

(3037522) Nuclear Ab [Titer] in Serum

1018

7485

1.43

22.19

1.4

titre

546.7

544.4

0.01

246

1561

(36660697) Celiac disease serology panel - Serum

648

4381

1.53

21.52

1.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1696

13615

1.34

21.47

2.1

2.0

u/l

201.9

187.6

0.12

1597

12789

(3032080) INR in Blood by Coagulation assay

2133

17700

1.31

21.34

9.4

7.6

inr

1.2

2.49

698

5231

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1134

8572

1.39

20.98

2.7

2.8

mmol/l

2.4

2.5

3.56

965

7500

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1271

9840

1.37

20.22

1.3

iu/ml

28.4

30.5

0.24

384

3172

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5409

51171

1.44

19.91

4.4

3.9

mmol/l

4.7

4.8

9.81

5052

47837

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1505

11997

1.34

19.68

2.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

123

503

2.47

19.29

1.9

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

813

5879

1.44

19.20

2.6

2.4

22.3

22.9

0.63

685

5013

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2794

24243

1.28

19.16

3.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5471

51942

1.44

19.02

4.8

4.3

mmol/l

2.8

2.9

3.10

5081

48243

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1133

8689

1.37

18.99

3.7

3.3

ng/l

229.7

371.9

1.22

794

6033

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3895

35290

1.28

18.38

3.1

2.9

u/l

41.5

41.7

0.06

3689

33159

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1200

9338

1.35

18.24

1.3

u/ml

7.6

11.0

1.21

444

3788

(3019309) Folate [Moles/volume] in Red Blood Cells

1020

7740

1.38

18.18

1.8

1.7

nmol/l

1096.8

1180.3

2.35

809

5918

(3026782) Osmolality of Urine

1142

8853

1.36

17.74

2.9

2.6

mosm/kgh2o

520.0

528.3

0.65

977

7478

(3037467) Urinalysis macro (dipstick) panel - Urine

3896

35375

1.27

17.68

4.6

4.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5360

50864

1.39

17.21

4.4

3.9

mmol/l

1.5

10.51

4990

47370

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1432

11527

1.31

17.10

2.1

1.7

mg/l

1.0

0.82

1072

8715

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5183

48936

1.36

17.06

3.9

3.5

mmol/l

1.2

0.11

4807

45351

(3020682) Albumin/Creatinine [Ratio] in Urine

1556

12701

1.30

16.70

4.3

3.8

mg/mmol

8.4

8.9

0.21

946

7654

(3012516) Albumin [Mass/volume] in Urine

1488

12104

1.30

16.33

3.5

3.1

mg/l

564.1

418.7

0.44

917

7236

(3009508) Creatinine [Moles/volume] in Urine

1628

13402

1.29

16.31

3.3

3.1

mmol/l

7.1

7.2

0.37

1366

11319

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1986

16802

1.27

15.87

3.1

u/l

29.0

32.6

2.42

1890

15962

(3010838) Calcium [Moles/time] in 24 hour Urine

225

2.95

14.83

1.5

1.6

mmol/24h

3.3

6.9

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

156

791

2.00

14.56

1.2

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

392

2602

1.54

14.06

1.2

1.1

titre

102.1

240.1

1.39

(3022217) INR in Platelet poor plasma by Coagulation assay

702

5222

1.39

13.89

22.5

20.6

inr

1.3

1.2

0.75

119

785

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1196

9646

1.30

13.67

1.7

1.6

pmol/l

46726625.9

37130673.4

0.21

1008

8147

(3021960) Folate [Moles/volume] in Serum or Plasma

1261

10261

1.29

13.43

1.5

nmol/l

20.4

21.1

0.92

1105

8798

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

337

2220

1.55

12.52

1.1

u/ml

1.9

1.8

—

(40768797) Stomach Pathology biopsy report

878

6868

1.32

12.46

1.3

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

601

4437

1.39

12.40

2.6

2.5

1.7

1.8

2.13

547

3951

(3002032) Base excess in Venous blood by calculation

489

3514

1.42

11.78

3.7

3.8

mmol/l

2.1

2.0

0.33

382

2894

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

478

3423

1.43

11.74

3.3

2.7

ng/l

218.2

166.4

0.71

429

3098

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

110

534

2.08

11.65

1.1

1.2

u/l

85.6

57.7

2.05

367

(3021447) Carbon dioxide [Partial pressure] in Venous blood

489

3525

1.42

11.57

3.8

kpa

5.9

5.8

1.02

469

3433

(40761536) Microorganisms panel - Urine sediment

576

4276

1.38

11.48

4.0

3.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

885

7006

1.31

11.46

1.8

—

(3030313) Adrenal Ab [Titer] in Serum

5.38

11.33

1.2

1.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

464

3334

1.42

11.18

2.2

2.5

g/l

65.8

66.9

2.42

428

3059

(3033658) Prothrombin time (PT) actual/Normal

1468

12393

1.24

11.17

4.0

3.6

92.0

94.5

3.35

1429

12064

(3000850) Epithelial cells [#/volume] in Urine

1173

9660

1.26

11.09

2.7

2.4

e6/l

7.1

0.04

1016

8393

(40768804) Tissue Pathology biopsy report

2485

22154

1.20

10.91

2.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

250

1589

1.60

10.89

1.1

u/ml

5.0

5.8

0.15

208

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

246

1563

1.60

10.73

1.3

u/ml

45.0

46.1

0.02

109

(3002582) Erythrocytes [#/volume] in Urine

1626

13933

1.23

10.67

3.5

2.9

e6/l

52.7

69.1

0.24

1255

10430

(3031040) Bacteria [#/volume] in Urine by Automated count

3679

34030

1.20

10.67

4.8

4.2

e6/l

1088.6

2360.9

0.96

400

(3041096) Erythrocytes [Presence] in Urine by Automated

1620

13928

1.22

10.21

3.6

3.1

—

(3018095) Leukocytes [#/volume] in Urine

1933

16940

1.20

9.95

4.0

3.4

e6/l

85.6

104.6

0.68

1360

11418

(3026493) Urate [Moles/volume] in Serum or Plasma

1416

12059

1.23

9.72

2.5

2.3

umol/l

4334.0

4044.0

0.09

1227

10557

(3025159) Blasts/100 leukocytes in Blood

484

3597

1.37

9.57

3.4

4.2

0.1

0.3

0.55

100

816

(3030467) Casts [#/volume] in Urine by Automated count

1491

12782

1.22

9.57

3.4

2.9

e6/l

0.3

0.4

1.25

1133

9407

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

246

2.45

9.57

1.2

1.1

u/l

15.5

22.8

1.00

188

(3023323) Follitropin [Units/volume] in Serum or Plasma

483

3594

1.37

9.48

1.4

1.3

iu/l

30.6

31.2

0.17

423

3150

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

234

1515

1.57

9.46

1.8

1.6

titre

200.0

308.0

0.50

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1522

13096

1.21

9.38

1.7

1.6

mmol/l

1.3

1.4

0.99

1255

11159

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

595

4581

1.33

9.34

3.2

3.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

504

3794

1.36

9.20

3.5

4.2

0.1

0.2

1.39

115

958

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

247

2.40

9.01

1.2

1.1

u/l

67.8

81.2

1.11

195

(3017181) Myelocytes/100 leukocytes in Blood

522

3964

1.35

9.00

3.4

4.2

0.9

0.09

118

1027

(3009542) Hematocrit [Volume Fraction] of Blood

5095

48890

1.23

8.95

17.9

13.1

39.8

39.5

2.27

3841

37358

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

277

1886

1.49

8.89

2.0

1.9

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

239

1583

1.53

8.75

1.6

1.8

g/l

0.2

0.45

221

1505

(3035350) Ketones [Presence] in Urine by Test strip

2757

25164

1.17

8.45

3.7

3.5

estimate

0.0

1.08

557

4544

(3005719) IgG [Mass/volume] in Serum or Plasma

481

3643

1.35

8.44

2.5

2.7

g/l

10.2

10.4

0.74

437

3367

(3027456) Digoxin [Moles/volume] in Serum or Plasma

122

687

1.79

8.44

3.8

3.0

nmol/l

0.8

0.84

104

524

(3048689) Calprotectin [Mass/mass] in Stool

843

6887

1.26

8.37

2.0

2.3

ug/g

121.2

111.5

0.27

655

5419

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

215

1408

1.55

8.31

1.3

u/ml

11.7

6.6

0.21

136

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

242

1626

1.51

8.31

1.6

1.8

g/l

1.2

0.29

222

1550

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

217

1427

1.54

8.24

1.3

u/ml

28.9

6.5

0.99

231

(3023520) Reticulocytes [#/volume] in Blood

436

3269

1.36

8.17

2.2

2.5

e9/l

71.7

70.7

0.21

335

2410

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

266

2.27

8.09

2.3

1.8

nmol/l

18.6

19.8

0.48

253

(36304419) Bacteria [Presence] in Urine

1458

12645

1.20

8.09

3.3

2.8

—

(3017732) Neutrophils [#/volume] in Blood

476

3624

1.34

8.07

2.7

e9/l

3.9

4.0

0.97

382

2920

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

188

1205

1.58

8.00

1.3

1.2

u/ml

48.7

43.0

0.19

135

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

287

2.21

7.97

1.1

nmol/l

3.7

10.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

475

3624

1.34

7.94

3.3

4.0

0.8

0.5

0.83

764

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

321

2303

1.42

7.86

2.9

3.4

mmol/l

2.1

1.9

0.50

234

1713

(3009261) Glucose [Presence] in Urine by Test strip

2786

25547

1.16

7.83

3.8

3.5

estimate

0.0

0.15

563

4576

(3021601) Nitrite [Presence] in Urine by Test strip

2762

25317

1.16

7.79

5.1

4.7

estimate

0.0

1.60

579

4626

(3009445) Proteinase 3 Ab [Units/volume] in Serum

274

1913

1.45

7.78

1.5

u/ml

8.1

16.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

443

3373

1.34

7.52

8.0

7.2

mmol/l

9.5

8.8

1.20

421

3234

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

248

1720

1.46

7.32

1.8

—

(3011985) Renin [Units/volume] in Plasma

107

607

1.78

7.28

2.6

1.4

mu/l

47.4

47.9

0.02

542

(3009343) pH of Capillary blood

329

2409

1.39

7.18

3.0

3.4

7.4

0.48

335

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

20.03

7.13

1.4

1.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

332

2442

1.38

7.05

3.0

3.4

kpa

5.3

5.2

1.17

310

2246

(3004616) Nuclear Ab [Presence] in Serum

109

628

1.75

7.05

1.2

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

207

1397

1.50

7.02

3.1

3.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

309

2253

1.39

6.92

1.3

u/ml

0.9

1.3

0.29

218

(3023368) Bacteria identified in Blood by Culture

1322

11527

1.19

6.76

4.3

4.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.14

6.70

1.3

ng/l

73.7

99.0

1.04

(3000991) Gas panel - Venous blood

428

3303

1.32

6.64

8.4

8.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

686

5619

1.25

6.62

2.8

2.6

umol/l

7.0

7.3

0.17

598

4779

(3022145) Colonoscopy Study observation

677

5545

1.25

6.53

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

327

2.00

6.44

1.5

1.6

u/l

6.3

5.2

0.28

163

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

260

1871

1.41

6.32

3.9

4.4

mmol/l

24.4

24.3

0.30

246

1693

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.17

6.28

1.5

—

(1761868) Lipid panel - Serum or Plasma

2137

19439

1.15

6.26

2.7

2.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

286

2105

1.38

6.09

2.1

2.0

u/l

40.6

39.5

0.38

261

1901

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

130

818

1.60

6.08

1.1

1.0

u/ml

2.9

3.3

0.17

413

(3007853) Bacteria identified in Skin by Aerobe culture

682

5648

1.23

5.95

2.0

1.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

235

1683

1.41

5.90

1.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

845

7157

1.21

5.89

3.1

2.6

e6/l

3.9

3.8

0.14

477

3655

(3004588) Protein electrophoresis panel - Serum or Plasma

356

2729

1.32

5.82

2.2

2.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

311

2340

1.35

5.78

3.6

3.3

g/l

131.6

128.2

1.99

303

2288

(3034274) Bile acid [Moles/volume] in Serum --fasting

132

846

1.57

5.74

2.0

2.2

umol/l

5.4

6.2

0.34

624

(3014111) Lactate [Moles/volume] in Serum or Plasma

446

3538

1.28

5.65

7.0

6.9

mmol/l

1.3

0.22

428

3422

(3003694) ABO and Rh group [Type] in Blood

1656

14883

1.15

5.63

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

212

1504

1.42

5.63

3.0

3.7

mmol/l

25.0

0.09

192

1380

(3024354) Oxygen [Partial pressure] in Venous blood

374

2904

1.31

5.59

3.3

3.1

kpa

4.6

0.15

358

2817

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

192

1340

1.45

5.57

2.2

2.1

mg/l

10.8

11.3

0.47

181

1253

(3024928) Oxygen saturation in Venous blood

130

838

1.56

5.53

3.2

3.6

—

(1616796) Gas panel - Central venous blood

132

855

1.56

5.50

2.8

3.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

569

4669

1.24

5.41

4.7

4.1

u/l

234.4

244.1

1.11

537

4407

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

517

1.71

5.41

3.1

3.0

nmol/l

3.5

15.8

0.60

501

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

379

2963

1.30

5.39

1.0

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

200

1418

1.42

5.35

1.3

titre

108.4

146.5

0.39

137

(3009214) Lutropin [Units/volume] in Serum or Plasma

187

1313

1.44

5.28

1.4

1.3

u/l

11.7

12.5

0.31

155

1088

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

167

1150

1.46

5.22

1.3

u/ml

1.0

2.7

1.15

(3000492) Spirometry study

600

4971

1.23

5.22

1.5

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

108

677

1.61

5.19

1.3

1.6

—

(3012565) Volume of 24 hour Urine

222

2.08

5.17

2.0

2.2

2057.7

1850.8

0.79

201

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

416

3315

1.27

5.11

1.7

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

364

2853

1.29

5.09

1.9

g/l

1.2

1.4

2.15

336

2640

(3026008) Bacteria identified in Urine by Culture

1712

15514

1.14

5.08

3.3

2.9

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

265

1995

1.34

4.95

1.6

1.5

mu/l

279.3

293.9

0.38

228

1789

(40759836) Histone Ab [Presence] in Serum by Immunoblot

413

1.75

4.86

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

413

1.75

4.86

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

413

1.75

4.86

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

414

1.75

4.82

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

414

1.75

4.82

1.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

128

850

1.52

4.81

2.4

ug/min

117.7

81.2

0.43

506

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

410

3288

1.26

4.79

2.2

ug/l

8.5

6.1

0.76

344

2849

(3021788) Differential panel - Synovial fluid

126

835

1.52

4.79

1.7

1.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

415

1.74

4.78

1.2

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

191

1380

1.40

4.64

2.1

2.3

ug/l

253.2

594.7

1.37

177

1276

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

382

1.76

4.63

1.4

1.2

u/ml

0.4

1.3

0.97

174

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3887

37160

1.12

4.59

3.3

3.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

340

1.80

4.55

1.3

1.4

umol/l

11.3

11.9

0.28

329

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

275

2112

1.32

4.51

9.2

9.1

mmol/l

24.5

24.3

0.34

261

1990

(3027273) Bicarbonate [Moles/volume] in Venous blood

238

1791

1.34

4.49

3.4

3.1

mmol/l

25.7

25.4

0.51

227

1742

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

552

4610

1.22

4.46

2.5

2.3

u/l

39.5

48.8

0.38

474

3924

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

297

0.30

4.45

13.7

12.4

nmol/l

750.1

859.9

—

285

(3029937) Albumin [Presence] in Urine by Test strip

1465

13243

1.14

4.43

4.0

3.9

estimate

0.0

1.98

567

4550

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

564

4725

1.21

4.42

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2108

19495

1.12

4.40

3.9

3.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

156

1103

1.42

4.31

2.1

2.3

g/l

0.0

0.00

149

1030

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

105

686

1.54

4.30

1.2

1.3

nmol/l

0.1

0.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

172

1241

1.40

4.24

2.0

2.2

g/l

38.2

0.08

157

1082

(3010421) pH of Blood

150

1059

1.43

4.19

2.9

3.4

7.4

1.62

124

892

(3008898) HLA-B27 [Presence]

276

2144

1.30

4.19

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

157

1118

1.41

4.18

2.1

2.2

g/l

0.0

0.50

149

1034

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

201

1494

1.36

4.14

2.0

2.3

g/l

3.1

0.08

165

1172

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

559

4713

1.20

4.11

1.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

451

3723

1.23

4.10

2.3

au/ml

21.1

25.8

0.45

245

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

341

2730

1.26

4.09

2.1

u/l

6176.3

5267.9

0.21

139

1102

(3022313) Gas panel - Capillary blood

226

1714

1.33

4.08

3.0

3.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1040

9235

1.15

4.06

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

338

1.75

4.06

1.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

183

1347

1.37

4.02

2.2

2.3

g/l

0.3

0.8

1.63

163

1186

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

672

5776

1.18

3.99

4.5

4.0

33.2

32.9

0.32

486

3951

(3030981) Hyaline casts [#/volume] in Urine by Automated count

279

2186

1.29

3.99

2.8

2.5

e6/l

0.2

0.39

269

2099

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

106

707

1.51

3.98

1.1

iu/ml

144.4

14310.3

0.55

169

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

140

987

1.43

3.96

3.0

3.8

57.8

57.5

0.08

140

987

(3024980) IgG subclass 4 [Mass/volume] in Serum

116

790

1.48

3.94

1.6

g/l

0.9

0.7

0.49

603

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

312

2484

1.27

3.93

2.5

2.3

—

(3015736) pH of Urine

2083

19349

1.12

3.92

3.3

—

5.9

—

(3016502) Oxygen saturation in Arterial blood

489

4091

1.21

3.91

7.3

7.5

95.3

96.0

1.25

462

3926

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

195

1458

1.35

3.89

2.2

2.3

g/l

9.9

10.3

0.87

170

1242

(3022621) pH of Urine by Test strip

413

3401

1.23

3.86

3.3

2.8

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

600

1.54

3.84

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

600

1.54

3.84

1.3

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

512

4315

1.20

3.80

2.2

g/l

0.2

0.13

475

4051

(3017143) Hepatitis C virus Ab [Presence] in Serum

726

6312

1.17

3.75

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

183

1364

1.35

3.74

1.5

1.4

ug/g

279.0

286.4

0.19

115

745

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

207

1572

1.33

3.74

2.1

2.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

551

4683

1.19

3.73

7.1

7.0

kpa

5.1

0.13

526

4464

(3003396) Base excess in Arterial blood by calculation

550

4674

1.19

3.73

7.0

mmol/l

1.2

1.1

0.12

425

3655

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

164

1203

1.37

3.71

2.1

2.2

g/l

0.0

0.55

156

1115

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

447

1.62

3.71

1.1

1.3

titre

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

207

1575

1.33

3.69

2.1

2.2

g/l

7.6

7.4

0.59

166

1203

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

165

1213

1.37

3.69

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

599

1.53

3.66

1.3

1.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

550

4682

1.19

3.66

7.1

7.0

kpa

12.3

12.9

1.78

525

4460

(3021879) Hepatitis B virus core Ab [Presence] in Serum

486

4093

1.20

3.64

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

624

1.51

3.64

1.2

1.3

—

(3003181) Sodium [Moles/volume] in Urine

108

738

1.47

3.63

1.3

mmol/l

68.3

62.1

0.75

582

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

305

1.74

3.63

1.1

1.2

u/l

18.3

18.6

0.02

266

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.48

3.62

1.8

2.0

mmol/l

6.9

7.1

0.10

(3028626) Oxygen [Partial pressure] in Capillary blood

120

838

1.44

3.61

2.5

3.0

kpa

8.2

8.3

0.16

111

769

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

206

1573

1.32

3.59

2.1

2.2

g/l

3.8

0.12

163

1136

(3042936) Bacteria identified in Isolate by Culture

743

6503

1.16

3.53

2.2

1.9

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

221

1710

1.30

3.51

2.2

2.0

nmol/l

10.3

11.2

0.68

198

1502

(3024522) Salmonella sp identified in Specimen by Organism specific culture

605

1.51

3.51

1.3

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

605

1.51

3.51

1.3

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

2.33

3.49

1.4

1.2

mu/l

68.2

59.1

0.09

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

277

2212

1.26

3.44

8.7

9.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

616

1.50

3.44

1.3

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

419

1.61

3.39

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

229

1791

1.29

3.37

2.0

1.7

g/l

1.5

0.55

194

1544

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

137

993

1.39

3.37

1.5

1.6

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.71

3.35

1.0

1.3

—

(3036603) Volume of Urine

298

1.72

3.34

1.7

1.5

1883.0

1901.2

0.03

(3000093) Morphology [Interpretation] in Blood Narrative

368

1.64

3.29

1.2

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

210

1630

1.30

3.29

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

315

1.69

3.27

1.1

1.2

u/l

69.8

80.7

0.46

281

(3039162) Centromere protein B Ab [Units/volume] in Serum

104

722

1.45

3.27

1.3

u/ml

71.4

54.9

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

592

5125

1.17

3.25

7.2

6.8

mmol/l

104.5

104.4

0.09

579

5025

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

872

7771

1.14

3.22

2.9

2.5

e6/l

1.3

1.4

0.06

495

4250

(3002256) Pathology report gross observation

765

6761

1.15

3.19

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

653

5705

1.16

3.19

4.8

4.6

ug/l

2.2

2.7

1.06

574

5115

(3012501) Base excess in Blood by calculation

125

902

1.39

3.18

3.0

3.4

mmol/l

2.5

0.11

604

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

307

0.36

3.18

13.4

17.7

nmol/l

1174.6

4575.2

0.57

298

(3008757) Leukocyte morphology finding [Identifier] in Blood

452

1.55

3.12

3.6

4.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

146

1085

1.35

3.11

1.7

1.3

e6/l

25.7

25.6

0.00

117

826

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

238

1.77

3.08

1.7

1.6

nmol/l

2.2

3.4

0.54

189

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.80

3.08

8.4

11.0

mmol/l

4.9

0.01

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

146

1087

1.35

3.08

1.7

1.4

e6/l

591.2

4668.4

0.64

123

875

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

307

2516

1.23

3.07

1.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

132

2.05

3.06

1.2

1.6

ug/l

0.5

0.4

0.56

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

146

1090

1.35

3.03

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

204

1.82

2.98

1.6

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

204

1.82

2.98

1.6

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

403

3409

1.19

2.93

1.3

au/ml

63.7

48.2

0.47

140

(3005322) IgE [Units/volume] in Serum or Plasma

415

3520

1.19

2.93

1.4

1.3

u/ml

153.6

189.2

0.97

387

3246

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

145

1088

1.34

2.92

1.3

u/l

26.9

29.2

0.35

117

901

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

101

714

1.42

2.92

1.4

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

375

1.58

2.85

1.2

titre

101.0

227.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

200

1.80

2.84

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

132

987

1.34

2.75

2.8

mmol/l

25.4

24.9

0.50

117

854

(3011648) Oxygen content in Venous blood

316

1.62

2.74

1.9

2.6

11.6

10.9

0.51

316

(3015183) Erythrocyte sedimentation rate

316

1.62

2.74

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

138

1.96

2.74

1.1

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

395

1.55

2.73

1.1

1.2

—

61.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

160

1.88

2.70

15.8

3.6

mg/l

71.6

1386.4

0.49

110

(3013139) Helicobacter pylori Ag [Presence] in Stool

426

3653

1.18

2.67

1.2

—

(4062490)

505

1.47

2.61

1.5

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

555

1.45

2.60

2.1

2.0

mg/l

26.1

25.7

0.01

142

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

698

1.40

2.58

1.6

1.7

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.90

2.58

1.1

u/l

29.5

9.2

0.38

(3028433) Virus identified in Specimen by Culture

170

1.83

2.58

1.0

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

673

1.40

2.57

3.1

3.4

0.9

1.3

1.15

528

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

474

1.48

2.57

1.5

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

116

862

1.35

2.54

2.3

2.4

16.6

16.3

0.27

432

(3006184) Hemoglobin [Mass/volume] in Capillary blood

128

966

1.33

2.53

2.1

2.2

g/l

133.3

128.2

1.56

697

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

129

975

1.33

2.53

1.5

1.6

—

(21494755) Public health laboratory ask at order entry panel

531

6036

0.87

2.51

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

749

6722

1.13

2.51

2.6

2.1

30.2

29.5

2.19

717

6501

(3021901) Oxygen saturation in Capillary blood

685

1.39

2.51

2.6

2.8

—

(3004451) EKG impression Narrative

179

1.79

2.50

1.3

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

365

1.54

2.47

2.6

2.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

271

1.63

2.46

1.5

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1219

11255

1.10

2.44

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

249

1.65

2.42

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

211

1.71

2.42

1.1

—

(4094501)

154

1202

1.29

2.41

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

265

1.63

2.40

1.5

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

548

1.43

2.39

1.6

54.3

55.7

0.11

345

(3051651) Icteric interference index of Serum or Plasma

281

1.61

2.39

3.7

3.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

144

1116

1.30

2.38

1.8

1.6

e6/l

10916.6

11392.4

0.05

104

807

(3002173) Hemoglobin [Mass/volume] in Arterial blood

442

3845

1.16

2.35

8.0

7.8

g/l

121.3

120.5

0.35

421

3688

(3028192) IgG subclass 2 [Mass/volume] in Serum

510

1.44

2.32

1.5

1.3

g/l

2.8

2.9

0.09

360

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

586

1.40

2.30

1.4

1.3

pmol/l

338.2

295.0

0.43

453

(3024139) IgG subclass 3 [Mass/volume] in Serum

511

1.43

2.30

1.5

1.3

g/l

0.3

0.4

2.83

357

(3027135) IgG subclass 1 [Mass/volume] in Serum

511

1.43

2.30

1.5

1.3

g/l

6.0

6.7

1.57

358

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

437

1.47

2.29

1.6

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

4.62

2.27

1.0

1.2

3.0

2.8

—

(3006270) Folate [Moles/volume] in Blood

381

1.50

2.27

1.1

nmol/l

420.2

385.9

0.69

343

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

188

1516

1.25

2.27

1.1

1.2

—

(3000330) Specific gravity of Urine by Test strip

281

2362

1.20

2.26

3.3

3.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

517

4564

1.14

2.25

4.0

24.0

21.3

2.44

212

2109

(3023410) Appearance of Cerebral spinal fluid

497

1.43

2.24

2.0

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

134

1038

1.30

2.24

4.2

4.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

224

1.66

2.23

1.0

1.1

—

(3037756) Immunofixation for Serum or Plasma

106

795

1.34

2.23

1.9

1.6

—

(3037121) Protein [Mass/volume] in Urine

189

1531

1.24

2.20

3.1

g/l

0.3

0.03

591

(21491868) Cryoglobulin [Mass/volume] in Serum

172

1.75

2.20

1.1

1.2

g/l

—

0.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

336

1.52

2.18

1.2

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

361

1.50

2.16

1.6

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

361

1.50

2.16

1.6

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

361

1.50

2.16

1.6

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

234

1.63

2.16

1.6

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

234

1.63

2.16

1.6

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

234

1.63

2.16

1.6

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

235

1.62

2.13

1.6

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

153

1215

1.27

2.12

1.9

2.0

—

(40757373) Influenza virus identified in Isolate

2.10

2.12

1.1

1.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

130

1014

1.29

2.09

1.4

1.3

—

(3025130) Human papilloma virus identified in Specimen

137

1076

1.28

2.09

1.8

1.7

—

(3006567) Chloride [Moles/time] in 24 hour Urine

5.00

2.07

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

2.06

0.0

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.50

2.05

1.0

1.2

u/l

274.9

410.6

—

(4035726)

501

4445

1.14

2.05

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

382

3327

1.16

2.03

2.8

2.9

ug/l

0.7

0.07

238

2126

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

635

1.36

2.03

1.1

g/l

1.5

0.02

577

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

298

2546

1.18

2.02

1.6

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

200

1647

1.22

2.02

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

208

1.64

2.00

1.6

2.5

umol/l

152.6

155.0

0.01

111

(3025941) Bacteria identified in Stool by Culture

350

3035

1.16

1.98

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

129

1014

1.28

1.97

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

118

918

1.29

1.95

6.3

5.5

iu/ml

320.2

967.7

0.95

115

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

313

1.51

1.94

1.0

1.1

—

(3047181) Lactate [Moles/volume] in Blood

170

1383

1.24

1.94

4.7

5.7

mmol/l

1.2

0.08

146

1208

(3017354) Segmented neutrophils/100 leukocytes in Blood

412

1.44

1.93

3.3

3.5

57.8

55.9

0.22

275

(3003327) Ova and parasites identified in Stool by Light microscopy

224

1875

1.20

1.93

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

184

1511

1.22

1.93

2.3

1.9

ug/l

1.9

2.0

0.04

162

1334

(3044927) Protein electrophoresis panel - Urine

371

1.46

1.93

1.4

1.2

—

(3016750) Collection duration of Urine

226

1.60

1.92

1.5

2.2

min

499.0

501.5

0.07

174

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

565

1.37

1.91

1.4

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

531

1.38

1.91

1.6

—

(1002224) Polysomnography panel

251

2130

1.19

1.87

1.1

—

(3035880) pH of Pleural fluid

189

1.64

1.86

1.1

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

399

3511

1.15

1.86

1.4

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

517

1.38

1.85

1.3

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

317

1.49

1.85

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

105

812

1.30

1.84

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

119

936

1.28

1.83

1.4

u/ml

147.5

114.4

0.46

193

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

153

1241

1.24

1.82

1.5

1.3

mg/l

471.7

486.9

0.21

143

1178

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

368

1.44

1.81

1.1

ratio

1.1

1.0

0.01

126

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

486

1.38

1.80

1.4

mmol/l

17.0

11.9

1.29

(46235355) HIV 1 and 2 tests - Meaningful Use set

1162

10857

1.09

1.79

1.8

1.9

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

344

1.46

1.79

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.76

1.79

1.3

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

142

1145

1.25

1.78

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.03

1.74

1.1

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

397

1.41

1.72

1.7

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

110

1.82

1.72

1.2

1.1

pmol/l

360.4

299.9

0.16

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

154

1259

1.23

1.72

4.2

3.3

u/ml

0.4

0.01

709

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

266

1.51

1.70

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

107

840

1.28

1.70

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

118

1.78

1.69

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

118

1.78

1.69

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

118

1.78

1.69

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

118

1.78

1.69

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.91

1.69

1.2

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

156

1.67

1.68

2.0

2.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

300

1.47

1.67

1.7

1.6

u/l

6.2

5.3

0.43

250

(3028679) Herpes simplex virus Ab [Presence] in Serum

292

1.48

1.66

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

310

2705

1.15

1.66

1.3

1.4

—

(44790048)

468

1.37

1.66

1.5

—

(44790047)

468

1.37

1.66

1.5

—

(44806118)

468

1.37

1.66

1.5

—

(44790049)

468

1.37

1.66

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

114

906

1.26

1.65

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

271

2345

1.16

1.63

1.4

—

(3019977) pH of Arterial blood

213

1.55

1.61

1.9

3.5

7.4

0.18

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

703

6458

1.10

1.60

1.8

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

254

1.50

1.59

2.4

1.7

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.07

1.59

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

190

1.58

1.59

1.7

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

190

1.58

1.59

1.7

1.8

—

(3023183) Ammonium ion [Moles/volume] in Plasma

101

795

1.27

1.59

2.2

3.0

umol/l

31.1

33.0

0.45

687

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.00

1.58

1.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

191

1.57

1.56

1.7

1.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

223

1.53

1.56

1.2

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

665

6101

1.10

1.56

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

149

1229

1.22

1.55

3.4

3.1

mg/l

35.9

55.8

1.90

112

981

(3044290) Cell count panel - Cerebral spinal fluid

127

1031

1.24

1.54

1.7

1.4

—

(3022475) Manganese [Moles/volume] in Blood

2.43

1.53

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

145

1195

1.22

1.53

3.4

3.0

ratio

1.2

1.5

—

101

(3000494) Fungus identified in Specimen by Culture

631

5781

1.10

1.52

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

149

1232

1.21

1.52

3.3

3.1

mg/l

27.8

41.2

1.68

112

985

(3022806) Fractional oxyhemoglobin in Capillary blood

528

1.33

1.51

1.8

1.7

89.5

90.0

0.21

518

(4010399)

388

3466

1.13

1.49

1.5

1.4

—

(3008295) Osmolality of Serum or Plasma

444

1.35

1.48

1.5

1.4

mosm/kgh2o

279.9

276.8

0.40

342

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

104

831

1.26

1.47

1.4

1.5

—

(4146454)

419

1.36

1.46

3.5

2.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

242

2099

1.16

1.45

1.6

1.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

498

1.33

1.44

1.1

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

132

1086

1.22

1.44

1.4

1.2

mmol/l

3.8

3.7

0.63

126

1025

(3051611) Lipemic interference index of Serum or Plasma

481

1.33

1.43

3.7

3.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

171

2018

0.84

1.42

2.0

—

(3017569) Oxygen content in Arterial blood

180

1.56

1.42

2.1

2.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

116

943

1.23

1.42

1.2

1.3

ug/l

2.4

3.8

2.18

100

833

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

295

1.43

1.41

1.3

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

483

1.33

1.40

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

152

1273

1.20

1.39

2.2

1.6

—

(4211845)

272

1.44

1.36

3.2

—

(40768443) Skin Pathology biopsy report

250

2185

1.15

1.36

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

173

1469

1.18

1.36

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

143

1.61

1.34

1.1

—

(3020491) Glucose [Moles/volume] in Blood

349

1.38

1.34

1.7

1.9

mmol/l

6.6

6.3

0.34

252

(3045414) Leukocytes [Presence] in Urine

271

2386

1.14

1.33

1.7

1.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

735

1.26

1.33

1.4

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

384

1.36

1.32

1.0

u/ml

0.3

2.1

1.07

113

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.78

1.32

2.0

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

369

1.36

1.29

1.1

1.2

—

(3006462) Nitrate [Presence] in Urine

251

1.44

1.28

2.7

3.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

439

1.32

1.27

1.5

1.7

—

(3014271) Vancomycin [Susceptibility]

186

1.51

1.26

2.5

2.9

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

371

1.35

1.25

1.1

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

546

1.29

1.24

1.9

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

141

1188

1.19

1.24

1.6

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

346

1.36

1.24

1.2

1.1

—

(3019060) Gas panel - Arterial blood

294

2621

1.13

1.22

4.1

4.8

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

180

1.50

1.20

1.0

1.1

ng/l

1982.0

1029.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

172

1.51

1.20

2.7

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

213

1.46

1.20

1.2

1.8

umol/l

1.8

2.0

0.96

198

(3004775) Volume in Urine collected for unspecified duration

297

1.38

1.20

1.7

2.3

591.4

638.2

0.45

209

(3003740) Influenza virus B Ag [Presence] in Specimen

110

909

1.21

1.19

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

125

1047

1.20

1.18

1.5

1.4

nmol/l

0.5

0.4

0.08

819

(40760888) Immunoglobulin light chains.free panel - Serum

110

911

1.21

1.17

3.6

3.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.70

1.17

1.4

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

231

1.43

1.17

2.0

1.5

nmol/l

1.3

1.4

0.12

180

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

552

1.27

1.16

1.1

—

3.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

273

0.62

1.16

1.0

ng/l

589.5

743.4

0.85

189

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

195

1699

1.15

1.2

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

624

1.25

1.15

1.3

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

158

1.52

1.14

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

116

969

1.20

1.14

1.2

u/ml

281.4

281.0

0.00

619

(3016038) Potassium [Moles/volume] in Urine

266

1.39

1.14

1.0

1.2

mmol/l

37.2

33.9

0.41

228

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

404

1.31

1.13

1.6

1.5

33.1

32.4

0.04

247

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

396

1.32

1.12

1.1

1.0

—

(3019174) dRVVT (LA screen)

1.96

1.11

1.0

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.26

1.10

1.3

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

109

909

1.20

1.10

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

285

1.37

1.10

1.7

1.5

u/ml

35.4

21.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

168

1.49

1.09

1.1

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

486

1.28

1.09

14.3

4.5

mmol/l

7.6

7.4

0.13

403

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.82

1.08

1.1

1.3

mmol/l

1.6

1.8

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

174

1512

1.16

1.08

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

666

6224

1.08

1.6

1.7

—

(3044941) Cell count panel - Synovial fluid

730

1.22

1.07

1.8

1.4

—

(3017704) Immunofixation for Urine

186

1.45

1.05

2.1

1.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.96

1.03

2.7

1.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

100

834

1.20

1.02

1.7

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

100

834

1.20

1.02

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

175

1529

1.15

1.02

1.2

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

826

1.20

1.01

1.4

mmol/l

6.9

7.0

0.06

602

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

275

0.65

1.01

1.0

ng/l

38.4

45.6

0.27

191

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

529

1.25

0.99

6.3

6.1

mg/l

12.2

11.6

0.49

487

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

548

1.24

0.98

1.6

mmol/l

7.5

7.7

0.23

332

(42529406) Shigella sp [Presence] in Stool by Culture

175

1536

1.14

0.97

1.2

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.97

0.0

1.2

—

21.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.63

0.97

1.3

1.9

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

182

1.43

0.95

1.1

1.2

115.7

111.4

0.33

165

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

199

1.41

0.95

1.1

1.2

g/l

0.3

0.45

159

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.95

0.0

1.6

—

(3034988) Calcium [Moles/volume] in Capillary blood

1.65

0.94

2.6

1.5

mmol/l

1.2

0.68

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.22

0.93

1.0

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

303

1.32

0.93

1.1

1.0

u/l

1.2

1.1

0.41

137

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

101

1.59

0.93

1.1

1.0

ug/l

87.3

72.2

0.51

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

269

0.67

0.93

1.0

ng/l

269.8

342.9

0.54

190

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

185

1637

1.13

0.92

2.7

3.4

u/ml

170.2

1321.0

1.11

152

1387

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.82

0.92

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.14

0.91

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

126

1.51

0.91

1.1

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

322

1.31

0.91

2.0

1.9

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

110

1.55

0.90

1.1

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

210

1.38

0.90

1.3

1.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

701

1.20

0.89

1.1

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

276

2508

1.11

0.88

9.6

8.9

0.6

0.7

1.94

276

2493

(3022689) Creatine [Moles/volume] in Urine

111

1.53

0.87

1.2

1.3

—

(21494434) Karyotype in Bone marrow

323

0.71

0.87

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

155

1363

1.14

0.87

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

704

1.20

0.86

1.2

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.82

0.85

1.3

1.2

—

(4027681)

343

1.28

0.85

1.3

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

424

1.25

0.84

1.4

1.5

e6/l

1672.0

2239.2

0.58

313

(40762814) Titanium [Mass/volume] in Blood

1.76

0.83

2.6

2.2

ug/l

2.8

3.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

506

1.23

0.83

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

461

1.24

0.83

2.0

1.6

—

(3049717) Cytology report of Urine Cyto stain

139

1219

1.14

0.82

2.7

2.4

—

(4281824)

754

0.82

1.1

1.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.88

0.81

1.3

1.1

mmol/l

8.7

7.9

—

(3003338) MCHC [Mass/volume]

4633

45806

1.04

0.81

21.1

15.4

g/l

331.6

331.7

0.21

4614

45491

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

206

1.36

0.81

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

206

1.36

0.81

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.70

0.80

1.5

1.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.70

0.80

1.6

2.2

umol/l

1.4

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

436

1.24

0.80

1.2

1.1

mg/l

44.2

40.0

0.24

364

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1297

12499

1.05

0.79

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

181

1.38

0.79

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

189

1696

1.12

0.79

5.2

4.9

1.8

1.7

1.25

176

1572

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

195

2165

0.90

0.78

1.4

1.3

miu/ml

215.8

229.9

0.23

104

1066

(3009466) Valproate [Moles/volume] in Serum or Plasma

574

0.80

0.78

5.9

4.9

umol/l

393.1

365.4

0.74

494

(3041806) Other cells [#/volume] in Blood by Manual count

182

1.38

0.77

1.5

1.6

—

(3001186) Copper [Moles/volume] in Serum or Plasma

123

1.46

0.77

1.4

umol/l

15.8

17.1

0.68

114

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

208

1.35

0.77

1.3

1.7

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

132

1.44

0.75

3.3

2.7

ng/l

73.6

131.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

112

975

1.15

0.75

1.3

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

827

1.16

0.74

1.9

2.1

nmol/l

0.8

0.00

716

(3036489) Thrombin time

209

1894

1.11

0.74

2.5

2.0

22.9

21.2

0.74

177

1604

(3001964) Herpes simplex virus Ag [Presence] in Specimen

142

1.41

0.72

1.7

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

223

2032

1.10

0.72

1.4

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

462

1.21

0.71

1.3

1.5

g/l

30.6

32.8

0.60

420

(3020191) Ethanol [Moles/volume] in Serum or Plasma

336

1.25

0.70

1.2

1.6

promille

1.2

0.07

252

(3004716) Salmonella sp identified in Stool by Organism specific culture

322

2989

1.08

0.69

1.3

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.51

0.69

1.1

1.2

—

(40765096) Chromosome analysis panel by Banding

119

0.59

0.67

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

338

1.24

0.67

2.5

2.8

e6/l

679.3

827.5

0.49

149

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.49

0.66

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

0.53

0.66

2.2

1.4

5.5

24.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.79

0.66

1.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

145

1299

1.12

0.66

2.4

2.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.61

0.65

1.1

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

162

1462

1.11

0.65

3.3

2.6

g/l

3.5

3.6

0.90

156

1379

(3000034) Microalbumin [Mass/volume] in Urine

395

1.22

0.64

2.4

2.6

mg/l

14.5

41.2

0.91

276

(3012441) Differential panel - Pleural fluid

350

1.23

0.63

1.3

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

112

1.43

0.63

1.3

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.50

0.63

1.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

272

2522

1.08

0.62

9.8

8.9

93.9

94.2

0.36

272

2512

(3033923) Metanephrine [Moles/time] in 24 hour Urine

104

1.44

0.62

1.1

umol/24h

0.4

0.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

273

2532

1.08

0.62

5.9

6.8

mmol/l

24.8

24.6

0.29

251

2344

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

424

1.20

0.62

1.1

mg/l

252.2

238.7

0.18

371

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

208

1.30

0.61

1.1

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

191

1.31

0.60

1.6

2.4

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.2

—

21.6

—

(3001556) Androgen free Index in Serum or Plasma

1.57

0.60

2.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

110

976

1.13

0.60

1.8

—

(40760409) HLA-A [Type] by High resolution

0.00

0.60

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.60

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.60

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.60

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.60

0.0

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

873

1.14

0.59

1.2

u/ml

2.3

3.6

1.16

281

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.54

0.59

3.0

2.7

u/field

0.9

0.8

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.54

0.59

1.1

—

(3013862) HLA-DP [Type]

0.00

0.59

0.0

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

157

1.34

0.59

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

273

1.25

0.58

1.1

1.0

89.8

92.6

0.28

214

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

819

1.14

0.58

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

184

1686

1.09

0.57

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

132

1.36

0.57

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

167

1.32

0.56

11.2

11.3

—

(3006653) Thiamine [Moles/volume] in Blood

238

1.26

0.56

1.1

1.3

nmol/l

132.9

134.1

0.04

238

(3042631) Mycobacterium sp identified in Specimen

540

1.17

0.56

1.9

2.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

104

925

1.13

0.56

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

104

925

1.13

0.56

1.2

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

116

1039

1.12

0.56

4.1

3.3

mg/l

21.2

26.4

1.09

647

(3020650) Glucose [Presence] in Urine

148

0.68

0.55

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

148

0.68

0.55

1.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

184

1690

1.09

0.55

5.3

5.0

0.9

0.21

172

1567

(3033705) Calcium.ionized [Moles/volume] in Venous blood

449

1.18

0.55

3.4

2.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

177

1.30

0.54

1.0

u/ml

0.2

1.8

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

330

1.21

0.54

2.4

2.8

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

205

1893

1.09

0.54

1.3

1.4

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.50

0.54

3.4

3.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.48

0.53

1.1

1.2

—

(3025315) Body weight

1.54

0.53

6.0

4.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

518

4942

1.05

0.52

3.2

3.9

ug/l

14.6

27.1

0.75

397

3874

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.43

0.52

7.4

6.6

—

(40761535) Cells panel - Urine sediment

349

3694

0.94

0.51

3.4

—

(3039000) Anion gap in Blood

108

970

1.12

0.51

6.0

6.7

mmol/l

11.9

11.2

0.93

855

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

173

1592

1.09

0.51

2.7

2.1

94.2

93.8

0.08

158

1471

(3045788) Cell count panel - Pleural fluid

333

1.20

0.50

1.4

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.39

0.50

3.4

2.9

—

(3018572) Chloride [Moles/volume] in Blood

108

971

1.11

0.50

6.0

6.7

mmol/l

104.7

105.3

0.66

856

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

482

1.16

0.49

1.4

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

180

1.28

0.49

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

279

0.79

0.48

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

204

1896

1.08

0.48

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

203

1887

1.08

0.48

1.3

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

190

1.26

0.47

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.49

0.47

1.1

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

204

1898

1.08

0.47

1.3

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.46

0.46

1.1

umol/24h

1.3

1.7

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.43

0.45

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

237

1.22

0.45

1.3

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

375

1.17

0.45

1.9

2.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

350

3685

0.95

0.45

1.4

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

228

1.23

0.45

2.3

2.5

ug/l

16.4

256.0

0.97

213

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

818

1.11

0.44

1.1

116.1

118.9

0.35

740

(3045424) Erythrocytes [Presence] in Urine

867

1.11

0.43

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

161

1491

1.08

0.43

1.8

—

(3024932) HLA-DR beta [Type]

140

0.71

0.43

1.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.61

0.43

3.6

2.1

—

(3011412) CD3 cells [#/volume] in Blood

508

1.14

0.43

2.5

2.4

e9/l

1.4

1.2

0.31

310

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.64

0.42

3.8

1.9

umol/l

14.0

16.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

212

1.23

0.42

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.43

0.41

1.2

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.52

0.41

1.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.8

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.41

0.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

107

976

1.10

0.41

1.0

1.1

u/ml

1.3

1.9

0.27

231

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.40

0.0

11.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

115

1054

1.09

0.40

1.0

1.1

u/ml

3.3

5.5

1.55

529

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

246

2605

0.94

0.40

1.4

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

347

0.83

0.40

1.1

1.4

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

814

0.90

0.40

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.31

0.39

4.6

5.3

—

(3048879) Bone marrow aspiration report

101

0.69

0.39

1.1

2.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.34

0.39

2.1

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

447

1.14

0.38

1.2

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

110

1198

0.92

0.38

3.3

4.1

mmol/l

3.9

3.8

0.45

104

1130

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

160

1.25

0.38

1.8

2.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

101

923

1.10

0.38

1.1

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

377

0.85

0.38

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.34

0.38

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

308

1.17

0.37

1.3

1.6

—

(4212803)

1.35

0.37

1.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.35

0.37

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

114

0.70

0.37

1.8

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

125

1.28

0.36

1.3

1.7

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.39

0.36

1.2

1.3

—

(21494815) CD4 cells/100 lymphocytes in Specimen

421

1.14

0.36

2.0

2.2

41.3

44.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.27

0.36

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

189

1.22

0.36

2.4

3.2

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

146

0.75

0.36

1.6

1.2

112.8

108.1

0.15

137

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.43

0.35

1.2

1.0

—

1.6

—

(4133840)

122

0.74

0.35

1.3

1.2

—

(3042733) HLA Ab [Presence] in Serum

135

1.26

0.35

5.1

4.9

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

175

1644

1.07

0.35

1.6

iu/ml

0.4

0.3

0.10

336

(3028308) Erythrocytes [#/volume] in Pleural fluid

376

1.14

0.34

1.4

1.5

e6/l

13113.0

56048.8

1.79

225

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.33

0.33

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.30

0.33

1.0

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.30

0.33

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

109

1009

1.08

0.33

1.0

1.1

u/ml

0.5

1.2

1.95

398

(3011288) Drugs identified in Urine by Screen method

133

1424

0.93

0.33

1.8

3.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1204

11802

1.03

0.32

3.3

3.5

—

(4306422)

847

1.09

0.32

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

125

1167

1.07

0.31

1.1

u/ml

3.1

1.3

0.69

433

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.35

0.31

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

380

1.13

0.31

1.0

u/ml

0.3

0.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

314

1.15

0.31

1.8

1.7

—

(40768795) Lymph node Pathology biopsy report

527

0.89

0.31

1.1

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.32

0.30

1.9

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.32

0.30

1.4

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.72

0.30

1.0

1.1

—

(3024471) HLA-A [Type]

142

0.77

0.30

1.0

—

(4034850)

156

1655

0.94

0.30

11.8

8.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

133

1248

1.07

0.29

1.4

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

110

1026

1.07

0.29

1.6

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.28

0.28

7.6

7.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.29

0.28

2.1

2.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

413

1.11

0.27

1.9

2.0

10.4

13.2

1.78

197

(3025577) Chromium [Mass/volume] in Blood

236

0.85

0.26

2.2

2.0

ug/l

1.8

2.6

1.07

203

(3026389) Candida sp identified in Specimen by Organism specific culture

828

1.08

0.26

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

132

1.21

0.25

1.1

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.23

0.25

6.0

6.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

114

1.23

0.25

1.1

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

179

1.17

0.25

1.5

1.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

105

1.24

0.24

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

159

0.82

0.24

1.6

2.3

e6/l

656.7

846.0

—

111

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

618

1.09

0.24

1.2

u/l

18.4

32.9

1.37

526

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

792

1.07

0.24

1.2

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

120

1132

1.06

0.24

2.5

3.3

mg/l

1.6

1.5

0.71

113

1055

(3045142) Bone marrow Pathology biopsy report

454

0.90

0.23

1.1

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

370

0.89

0.23

2.5

1.9

u/field

2.3

2.2

0.04

157

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.32

0.23

6.0

2.7

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

106

1.23

0.23

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

380

1.11

0.23

2.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.28

0.23

1.4

umol/l

58.8

40.8

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.28

0.23

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.76

0.22

1.3

2.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

381

1.10

0.22

3.5

3.9

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.22

0.22

6.0

2.6

mg/l

33.0

20.5

—

(3050794) Legionella sp Ab [Presence] in Serum

1.22

0.22

1.2

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

210

1.14

0.21

1.4

1.5

5.3

4.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

124

0.81

0.21

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

336

0.89

0.21

1.2

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

163

1.17

0.21

1.8

2.7

umol/l

31.7

28.5

0.47

123

(3022670) pH of Venous cord blood

0.00

0.21

0.0

1.2

—

(3036180) Methadone [Presence] in Urine

0.00

0.21

0.0

2.8

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.21

0.0

2.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.21

0.0

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.21

0.0

1.2

—

7.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.21

0.0

1.2

—

4.4

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.21

0.0

1.2

—

71.4

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

2.1

—

(3006598) pH of Arterial cord blood

0.00

0.21

0.0

1.2

—

(40768806) Pleura Pathology biopsy report

382

1.10

0.21

1.7

1.5

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3019150) Specific gravity of Urine by Refractometry

1104

10878

1.02

0.21

4.0

3.9

kg/l

1.0

0.08

194

1679

(3032057) Clostridioides difficile [Presence] in Stool

102

0.78

0.21

1.4

1.8

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

760

1.07

0.20

1.3

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

117

1.20

0.20

1.7

3.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

117

1.20

0.20

1.7

3.9

—

(3037556) Urate [Mass/volume] in Serum or Plasma

123

0.81

0.20

1.1

1.3

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.20

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.20

0.0

5.5

—

367.6

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.20

0.0

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

185

1924

0.96

0.20

1.8

1.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.25

0.20

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

1.25

0.20

1.0

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

800

0.94

0.20

1.1

u/ml

1.4

3.5

1.98

312

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

355

1.10

0.20

1.2

1.4

nmol/l

1.4

1.5

0.15

320

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

269

1.12

0.19

2.1

2.6

41.8

42.2

0.03

(3025018) Bordetella pertussis Ab [Titer] in Serum

344

0.90

0.19

1.1

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

212

1.13

0.19

1.8

2.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.22

0.19

1.8

2.0

—

(3014891) Appearance of Pleural fluid

1.15

0.19

1.5

1.7

—

(3047189) Immunofixation for 24 hour Urine

175

1.14

0.18

2.3

1.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

704

0.94

0.18

1.0

u/ml

0.2

0.3

—

142

(3036670) Protein [Mass/volume] in Synovial fluid

128

1.17

0.18

1.4

1.3

g/l

44.1

38.8

—

(40762365) Oxygen content in Arterial blood by calculation

1.21

0.18

1.7

2.5

ml/dl

15.9

15.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

367

1.09

0.18

2.7

2.5

e6/l

453.8

544.4

0.82

308

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

153

0.85

0.18

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.17

0.17

1.3

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

237

0.89

0.17

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

513

1.07

0.17

1.1

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

268

0.90

0.17

2.0

1.8

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

163

0.86

0.17

1.1

1.0

—

7.6

—

(3020891) Body temperature

149

1548

0.96

0.17

4.1

4.4

—

(3024263) Appearance of Synovial fluid

215

1.12

0.16

2.7

1.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

120

1.17

0.16

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.13

0.16

1.0

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.13

0.16

1.8

2.8

—

18.9

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.11

0.16

2.8

2.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

564

1.06

0.16

1.1

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

130

0.85

0.16

1.1

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.78

0.15

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.78

0.15

1.0

—

(40758292) HTLV I+II Ab panel - Serum

0.77

0.15

1.2

1.4

—

(3028300) Cannabinoids [Presence] in Urine

204

2102

0.97

0.15

1.5

2.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.21

0.15

6.9

7.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

528

5373

0.98

0.15

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

332

1.08

0.15

1.7

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

429

1.07

0.15

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

159

1.13

0.15

1.7

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

264

0.91

0.14

1.7

2.9

—

(3027008) Opiates [Presence] in Urine

204

2094

0.97

0.13

1.5

2.0

—

(40768441) Liver Pathology biopsy report

376

0.93

0.13

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

662

6534

1.01

0.12

1.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

345

1.07

0.12

1.5

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

423

1.06

0.12

1.4

e6/l

24839.3

46578.5

0.47

294

(3000012) Reticulocyte production index

219

1.10

0.12

1.3

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

317

1.07

0.12

1.1

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

220

1.09

0.11

1.3

1.6

—

1810015.3

—

(3027944) Amphetamines [Presence] in Urine

202

2068

0.98

0.11

1.5

2.1

—

(3044007) Cell count panel - Peritoneal fluid

126

0.87

0.11

1.7

2.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

153

1489

1.03

0.11

3.7

2.4

166.6

182.3

2.01

146

1413

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

838

1.04

0.11

1.3

1.2

u/ml

3.1

4.1

0.73

337

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

192

1.09

0.10

1.0

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

851

0.96

0.10

1.0

u/ml

3.8

3.7

0.02

310

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

146

0.89

0.10

1.2

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

125

0.88

0.10

1.2

1.3

nmol/l

97.9

106.9

0.13

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

352

3575

0.98

0.10

1.7

—

(40768793) Breast Pathology biopsy report

158

1619

0.98

0.10

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

259

0.93

0.10

2.8

1.7

u/field

1.0

2.6

2.30

183

(3033799) Differential panel - Peritoneal fluid

135

0.89

0.09

1.6

2.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.09

0.09

1.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

207

0.92

0.09

1.2

1.1

86.3

94.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

155

1.10

0.09

3.7

3.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

596

1.04

0.09

1.2

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.03

0.08

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.03

0.08

3.7

2.6

—

(3017509) Phencyclidine [Presence] in Urine

0.82

0.08

1.0

1.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

371

1.05

0.08

1.2

1.4

nmol/l

21.4

32.6

2.21

337

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

117

1.11

0.08

1.1

—

(44813793)

421

1.05

0.07

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

392

3876

1.01

0.07

2.8

2.4

ml/min/173m2

67.9

70.3

0.53

169

1460

(3000764) Benzodiazepines [Presence] in Urine

205

2084

0.98

0.07

1.5

2.1

—

(3045716) Anion gap in Serum or Plasma

186

1.08

0.07

4.7

2.5

mmol/l

9.6

9.2

0.35

145

(3042111) Morphology [Interpretation] in Bone marrow Narrative

639

1.03

0.07

1.6

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.03

0.07

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.03

0.07

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.03

0.07

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

571

1.03

0.06

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

285

1.05

0.06

1.3

—

(3036048) Francisella tularensis Ab [Titer] in Serum

101

0.89

0.06

1.1

—

262.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

569

5646

1.01

0.06

6.3

6.0

—

(4268621)

578

0.97

0.06

2.2

2.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

119

1.09

0.06

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

618

6140

1.01

0.05

1.5

1.7

1.3

1.4

1.18

544

5474

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

202

0.94

0.05

1.2

86.2

96.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

161

0.93

0.05

2.9

2.2

nmol/l

160.7

151.9

0.11

135

(3023419) Bacteria identified in Sputum by Culture

535

0.97

0.05

3.5

2.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

120

1.08

0.04

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

458

4611

0.99

0.04

1.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

170

0.94

0.04

2.9

4.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

154

1559

0.99

0.04

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

372

0.97

0.04

1.0

1.1

iu/ml

4.7

9.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

378

1.03

0.04

1.5

1.7

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

299

1.04

0.03

1.0

1.6

ug/l

14.3

8.8

0.27

263

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

349

1.03

0.03

1.7

1.8

mg/l

3.4

0.04

333

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

169

0.95

0.03

1.1

1.4

pmol/l

162.7

217.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.09

0.03

1.2

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

391

3889

1.01

0.03

3.2

3.4

u/ml

51.5

49.5

0.06

374

3764

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

102

1.08

0.03

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

108

0.93

0.03

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

641

0.98

0.02

2.5

—

(3005033) Fetal Nuchal fold Thickness US

154

1554

0.99

0.02

1.3

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

162

1606

1.01

0.02

1.4

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

182

1.04

0.02

3.3

3.5

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

258

0.97

0.02

3.1

2.7

—

31.6

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

137

0.95

0.01

1.4

2.0

e6/l

2822.0

22258.9

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

849

0.99

0.01

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

357

0.98

0.01

1.2

1.1

—

(4015189)

104

1.06

0.01

2.3

2.4

—

(3002619) Bacteria identified in Specimen by Culture

106

0.94

0.01

1.2

1.3

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

146

0.96

0.00

1.2

1.1

u/ml

54.5

51.6

0.06

139

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

204

1.03

0.00

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

221

2217

1.00

0.00

1.9

1.7

mg/l

3.3

3.6

0.27

173

1535

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

416

0.99

0.00

2.9

2.7

—

(3016879) Cocaine [Presence] in Urine

191

1904

1.00

0.00

1.5

2.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

736

7366

1.00

0.00

2.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

188

1.01

0.00

1.1

1.2

—

(44806420)

1.05

0.00

1.7

2.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

205

1.02

0.00

1.9

2.4

umol/l

46.2

53.2

0.82

177

(4198724)

215

0.98

0.00

1.2

2.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

285

1.02

0.00

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

264

0.98

0.00

1.1

miu/ml

1543.0

1501.4

0.06

264

(3000060) B lymphocytes [#/volume] in Blood

153

0.98

0.00

1.9

2.0

e6/l

203.0

152.9

—

(3009871) Measles virus Ab [Titer] in Serum

203

0.99

0.00

1.7

—

(4024509)

484

0.99

0.00

1.6

1.5

—

(40768800) Prostate Pathology biopsy report

337

1.01

0.00

1.1

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

393

0.99

0.00

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

0.99

0.00

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

149

1.01

0.00

1.7

1.6

ug/l

9.0

8.6

0.09

149

(3034426) Prothrombin time (PT)

179

1.01

0.00

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

181

0.99

0.00

2.2

2.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

159

1589

1.00

0.00

1.6

2.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

123.1

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

35.2

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

0.94

0.00

1.5

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.8

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.93

0.00

1.0

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

6.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.90

0.00

1.2

1.3

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(44806071)

0.92

0.00

1.1

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.6

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.85

0.00

1.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

880

1.00

0.00

1.7

2.9

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

110

1.00

0.00

1.1

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.6

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

3.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3042517) Benzodiazepines panel - Urine

0.86

0.00

1.4

2.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

900

1.00

0.00

3.2

3.3

u/ml

43.2

614.2

1.27

820

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.00

0.00

1.9

1.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_THYTOXGOITDIF and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_THYTOXGOITDIF	1.072 [0.97, 1.19]	0.195
Birth year	0.998 [0.99, 1.01]	0.668

During the follow-up period (1.1.1998 — 31.12.2019), 2220 out of 23978 females with E4_THYTOXGOITDIF died.

Males

Parameter	HR [95% CI]	p-value
E4_THYTOXGOITDIF	1.256 [1.11, 1.42]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 772 out of 5286 males with E4_THYTOXGOITDIF died.

Mortality risk

Mortality risk for people of age

years, who have E4_THYTOXGOITDIF.

N-year risk	Females	Males
1	0.133%	0.248%
5	0.717%	1.366%
10	1.728%	3.515%
15	3.315%	6.757%
20	5.89%	11.323%

Relationships between endpoints

↥

Index endpoint: E4_THYTOXGOITDIF – Thyrotoxicosis with diffuse goitre

GWS hits: 30

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Thyrotoxicosis with diffuse goitre

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints